Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 30Active not recruiting 7Unknown 4Terminated 4Withdrawn 3Recruiting 1

Sponsor Class

OTHER 91INDUSTRY 11NIH 10NETWORK 4UNKNOWN 2OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 2Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NETWORK × Rituximab × Clear all
NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Bioaraba Health Research Institute

Phase 4 Unknown
48 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT02423837 2015-04-22

BRiF

National Research Center for Hematology, Russia

Phase 3 Unknown
200 enrolled
Lymphoid

Lymphoma, Follicular

NCT02156726 2014-06-05

Q-lite

Czech CLL Study Group

Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00628238 2010-09-10

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia Research Consortium

Phase 2 Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡